Abstract
AbstractSuccessful treatment with the combination of low dose thalidomide and interferon‐α is described in an 89‐year‐old man who had chronic hepatitis C‐related metastatic hepatocellular carcinoma. Thalidomide 100 mg/day and interferon‐α2b 3 million units/week were prescribed. After 9 months of the combination therapy, his serum α‐fetoprotein level had declined from 24 549 ng/mL to less than 2.76 ng/mL. The recurrent liver tumors decreased in size and the metastatic lung lesions had complete remission after treatment. Combination therapy with lower dose interferon‐α and thalidomide, two antiangiogenic drugs with different mechanisms of action, was associated with a good response and was well tolerated in this preliminary study.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
